Subscribe
istock-506815322_artjazz
artjazz / iStockphoto.com
18 April 2019Generics

European Parliament approves SPC manufacturing waiver

The European Parliament has voted to approve the supplementary protection certificate (SPC) manufacturing waiver, which will allow the stockpiling of generic versions of patented drugs.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
SPC generics waiver comes into force
1 July 2019   The controversial supplementary protection certificate manufacturing waiver has come into force today, July 1.
Big Pharma
SPC waiver stockpiling provision attracts criticism
19 February 2019   While the final text of the European Council’s agreement on a supplementary protection certificate manufacturing waiver has yet to be released, the reported stockpiling provision has attracted criticism.
Generics
European Council agrees on SPC manufacturing waiver
15 February 2019   The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Big Pharma
SPC generics waiver comes into force
1 July 2019   The controversial supplementary protection certificate manufacturing waiver has come into force today, July 1.
Big Pharma
SPC waiver stockpiling provision attracts criticism
19 February 2019   While the final text of the European Council’s agreement on a supplementary protection certificate manufacturing waiver has yet to be released, the reported stockpiling provision has attracted criticism.
Generics
European Council agrees on SPC manufacturing waiver
15 February 2019   The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.

More on this story

Big Pharma
SPC generics waiver comes into force
1 July 2019   The controversial supplementary protection certificate manufacturing waiver has come into force today, July 1.
Big Pharma
SPC waiver stockpiling provision attracts criticism
19 February 2019   While the final text of the European Council’s agreement on a supplementary protection certificate manufacturing waiver has yet to be released, the reported stockpiling provision has attracted criticism.
Generics
European Council agrees on SPC manufacturing waiver
15 February 2019   The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB